Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma

Authors :: Stella P. Breininger
Oliver J Pickering
Zoë S. Walters
Timothy J. Underwood
Source :: Cancers, Vol 13, Iss 4084, p 4084 (2021), Cancers
Publication Year :: 2021
Publisher :: MDPI AG, 2021.
Abstract: Simple Summary Despite advances in both the surgical and medical management of oesophageal adenocarcinoma (OAC), overall prognosis remains poor, with less than 1 in 5 patients surviving more than 5 years from diagnosis. Patients suitable for treatment with curative intent receive pre-operative chemotherapy, but few (

Tools